# Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer

> **NCT06115174** · PHASE4 · UNKNOWN · sponsor: **Tanta University** · enrollment: 44 (estimated)

## Conditions studied

- Metastatic Colorectal Carcinoma

## Interventions

- **DRUG:** Pentoxifylline
- **RADIATION:** FOLFOX
- **RADIATION:** XELOX
- **DRUG:** Monoclonal antibodies (target therapy)

## Key facts

- **NCT ID:** NCT06115174
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06115174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06115174, "Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06115174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*